Bristol-Myers Squibb Co. (BMY) PT Raised to $66 at Truist Securities
Get Alerts BMY Hot Sheet
Price: $56.90 -2.12%
Rating Summary:
11 Buy, 23 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 23 | New: 41
Rating Summary:
11 Buy, 23 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 23 | New: 41
Join SI Premium – FREE
Truist Securities raised its price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $66.00 (from $65.00) while maintaining a Hold rating.
You May Also Be Interested In
- Best Idea Q3 2026: Ryanair (RYAAY) PT Raised to $79 at Bernstein SocGen
- General Mills (GIS) PT Raised to $33 at UBS, Sell Rating Maintained
- Revolution (RVMD) PT Raised to $220 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share